Showing results (1381-1390 of 1,513) with videos related to

Sort By:
Pageof 152
Thorax|August 22, 2024
Consensus palliative care referral criteria for people with chronic obstructive pulmonary diseaseJennifer Philip, Yuchieh Kathryn Chang, Anna Collins, et al.
Scientific Reports|May 29, 2013
Skin stem cell hypotheses and long term clone survival--explored using agent-based modellingX Li, A K Upadhyay, A J Bullock, et al.
Scientific Data|September 15, 2022
An Open MRI Dataset For Multiscale NeuroscienceJessica Royer, Raúl Rodríguez-Cruces, Shahin Tavakol, et al.
Chest|September 27, 2025
International Stakeholder Engagement on Clinical Care and Research for Sleep Assessment and Nocturnal Hypoxemia in Pulmonary FibrosisLeona Dowman, Shane Landry, Natasha Smallwood, et al.
Journal of Medicinal Chemistry|November 23, 2000
Design, synthesis, and biological evaluation of potent and selective amidino bicyclic factor Xa inhibitorsQ Han, C Dominguez, P F Stouten, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|May 23, 2019
Use of EHR-Based Pediatric Quality Measures: Views of Health System Leaders and ParentsDavid M Hartley, Susannah Jonas, Daniel Grossoehme, et al.
Nature Communications|May 9, 2022
Genetic and phylogenetic uncoupling of structure and function in human transmodal cortexSofie L Valk, Ting Xu, Casey Paquola, et al.
Journal of Medicinal Chemistry|October 5, 2007
Discovery of 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide (apixaban, BMS-562247), a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor XaDonald J P Pinto, Michael J Orwat, Stephanie Koch, et al.
Bioorganic & Medicinal Chemistry Letters|October 8, 2017
Discovery of renin inhibitors containing a simple aspartate binding moiety that imparts reduced P450 inhibitionBrian G Lawhorn, Tritin Tran, Victor S Hong, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. Part 4: Heterocycles at C3Eddy W Yue, Susan V DiMeo, C Anne Higley, et al.
Pageof 152